Germany’s booming market for dietary supplements has reached a new peak, with 415 million packs sold in 2025—nearly double the 2022 figure—fueling a €12 billion industry that critics warn is unregulated and potentially hazardous. The surge, documented by the *Tagesspiegel* on Friday, underscores the rapid expansion of a sector where consumers increasingly turn to pills and powders in pursuit of health, performance, or longevity, often without medical oversight.
The numbers reveal a market where demand outpaces scrutiny. In 2025 alone, Germans purchased 415 million packages of supplements, a 94% increase from 2022, according to industry data cited by the newspaper. The sector’s growth has been driven by aggressive marketing, social media trends, and a cultural shift toward self-optimization, with products ranging from vitamin D to protein powders and nootropics. Yet health experts and regulators have raised alarms over inconsistent quality controls, misleading health claims, and the potential for harmful interactions with medications.
The German Federal Office for Consumer Protection and Food Safety (BVL) has logged thousands of complaints annually about supplements, including undeclared ingredients and exaggerated efficacy promises. In 2024, the agency reported 3,200 adverse reactions linked to dietary supplements, though the actual number is likely higher due to underreporting. Critics argue that the current regulatory framework, which treats supplements as food rather than pharmaceuticals, is ill-equipped to address the risks. “The market is a Wild West,” said Dr. Anna Berg, a nutritionist at Charité Berlin. “Consumers assume these products are safe because they’re on shelves, but that’s not always the case.”
Industry representatives counter that the sector is maturing, with voluntary certifications and stricter labeling gaining traction. The German Nutrition Society (DGE) has called for mandatory pre-market approval of supplements containing novel ingredients, a proposal currently under review by the Federal Ministry of Food and Agriculture. However, progress has been slow, with lobbying groups resisting tighter regulations that could stifle innovation.
The debate comes as Germany grapples with broader public health challenges, including rising obesity rates and an aging population increasingly reliant on dietary aids. The supplement industry, meanwhile, shows no signs of slowing down. With sales projected to climb another 15% in 2026, the question is no longer whether the market will grow—but whether regulators can keep pace.
Follow us for live European news